Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Coral Gables, FL
SEC filing record 1 source field available
Fiscal year end
31 December
RELMADA THERAPEUTICS, INC. has filed 598 SEC EDGAR filings since 13 Nov 2012

SEC filing history

Showing 26-50 of 598 matching filings.

Per page
25
Current page
2
4

4 filing

Filing date
16 Dec 2025
Reporting date
12 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Dec 2025
Reporting date
12 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Dec 2025
Reporting date
12 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Dec 2025
Reporting date
12 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Dec 2025
Reporting date
12 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Dec 2025
Reporting date
12 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Dec 2025
Reporting date
12 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
15 Dec 2025
Reporting date
12 Dec 2025
Next action
Verify source filing
SCHEDULE 13G File 005-88207

SCHEDULE 13G filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
13 Nov 2025
Reporting date
13 Nov 2025
Next action
Verify source filing
10-Q File 001-39082

QUARTERLY REPORT

Filing date
13 Nov 2025
Reporting date
30 Sep 2025
Next action
Verify source filing
4

4 filing

Filing date
06 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Nov 2025
Reporting date
05 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
05 Nov 2025
Reporting date
04 Nov 2025
Next action
Verify source filing
424B5 File 333-281877

PROSPECTUS SUPPLEMENT

Filing date
05 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-281877

FREE WRITING PROSPECTUS

Filing date
04 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
04 Nov 2025
Reporting date
04 Nov 2025
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
17 Sep 2025
Reporting date
17 Sep 2025
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
16 Sep 2025
Reporting date
15 Sep 2025
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
10 Sep 2025
Reporting date
10 Sep 2025
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
02 Sep 2025
Reporting date
29 Aug 2025
Next action
Verify source filing
4

4 filing

Filing date
28 Aug 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88207

SCHEDULE 13G/A filing

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .